Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jed Magen, DO
Michigan State University
Principal Investigator - Joel Sanchez, MD
Michigan State University
Principal Investigator - John Carlson, PhD
Michigan State University
Principal Investigator - Justin Barterian, MA
Michigan State University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Michigan State University Psychiatry Clinic
East Lansing, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jan 2014
- Primary completion
- 30 May 2015
- Completion
- 30 May 2015
- Last update posted
- 18 May 2022
- Registered enrollment
- 6
- Registry id
- NCT05378711
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.